SK Capital agrees to acquire business from Catalent Pharma Solutions
The unit will operate as a newly independent company once the deal closes, which is expected in April 2021.
The unit will operate as a newly independent company once the deal closes, which is expected in April 2021.
Copyright PEI Media
Not for publication, email or dissemination